PUKYONG NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION
发明人:
김군도,손병화,조미정,KIM, GUN DOKR,SON, BYENG WHAKR,JO, MI JEONGKR
申请号：
KR1020160111087
公开号：
KR1017470440000B1
申请日:
2016.08.30
申请国别(地区):
KR
年份:
2017
代理人:
摘要：
The present invention relates to a pharmaceutical composition for preventing or treating cancer, which contains a novel cristazine compound, and a novel cristazine compound according to the present invention is characterized by having little cytotoxicity against normal cells, Cytotoxicity to cancer cells (skin cancer, cervical cancer, liver cancer) is very high, and thus may be useful as a therapeutic agent for a specific cancer.본 발명은 신규한 크리스타진(cristazine) 화합물을 함유하는 암 예방 또는 치료용 약학적 조성물에 관한 것으로, 본 발명에 따른 신규한 크리스타진(cristazine) 화합물은 정상세포에 대한 세포독성은 거의 없으면서, 특정 암세포(피부암, 자궁경부암, 간암)에 대한 세포독성은 매우 높으므로, 특정 암의 치료제로 유용할 수 있다.
